adrenomedullin receptor activity [MF]
outer ear morphogenesis [BP]
cell migration [BP],
negative regulation of mitotic anaphase-promoting complex activity [BP]
glutamate-cysteine ligase catalytic subunit binding [MF],
positive regulation of glutamate-cysteine ligase activity [BP]
Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP],
blood vessel morphogenesis [BP],
positive regulation of BMP signaling pathway [BP],
venous endothelial cell differentiation [BP],
nuclear condensin complex [CC],
branching morphogenesis of an epithelial tube [BP]
alpha-1,6-mannosyltransferase activity [MF],
lactoylglutathione lyase activity [MF],
proprioception involved in equilibrioception [BP]
organ formation [BP]
middle ear morphogenesis [BP],
myoblast migration [BP],
positive regulation of ureteric bud formation [BP],
kidney development [BP],
regulation of synaptic growth at neuromuscular junction [BP],
regulation of branch elongation involved in ureteric bud branching [BP],
sequence-specific DNA binding [MF],
metanephric mesenchyme development [BP],
embryonic cranial skeleton morphogenesis [BP],
branching involved in ureteric bud morphogenesis [BP],
positive regulation of branching involved in ureteric bud morphogenesis [BP],
thymus development [BP]
protein glycosylation in Golgi [BP]
epithelial tube formation [BP],
asymmetric protein localization [BP]
optic cup structural organization [BP],
optic vesicle morphogenesis [BP],
menstruation [BP],
embryonic eye morphogenesis [BP],
oxoglutarate:malate antiporter activity [MF]
response to redox state [BP]
metanephric nephron tubule morphogenesis [BP],
metanephric distal tubule morphogenesis [BP],
calcium-independent cell-matrix adhesion [BP],
polyamine homeostasis [BP],
cell-matrix adhesion [BP]
zinc transporting ATPase activity [MF],
3-demethylubiquinone-9 3-O-methyltransferase activity [MF],
hexaprenyldihydroxybenzoate methyltransferase activity [MF]
calcium ion-dependent exocytosis of neurotransmitter [BP],
methionine-R-sulfoxide reductase activity [MF],
negative regulation of cardiac muscle cell myoblast differentiation [BP]
E-box binding [MF]
8-oxo-dGDP phosphatase activity [MF],
8-oxo-GDP phosphatase activity [MF],
dADP catabolic process [BP],
dGDP catabolic process [BP],
8-hydroxy-dADP phosphatase activity [MF]
1-acylglycerophosphocholine O-acyltransferase activity [MF]
(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity [MF]
regulation of potassium ion transport [BP]
ATP binding [MF]
protein tyrosine kinase activity [MF]
adenohypophysis morphogenesis [BP]
bud dilation involved in lung branching [BP],
negative regulation of metanephric comma-shaped body morphogenesis [BP],
specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway [BP],
negative regulation of glomerulus development [BP],
negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway [BP],
negative regulation of mesenchymal cell proliferation involved in ureter development [BP],
lens development in camera-type eye [BP],
negative regulation of cell proliferation involved in heart morphogenesis [BP],
negative regulation of metanephric S-shaped body morphogenesis [BP],
pulmonary artery endothelial tube morphogenesis [BP],
positive regulation of branching involved in lung morphogenesis [BP],
BMP signaling pathway involved in nephric duct formation [BP],
intermediate mesodermal cell differentiation [BP],
BMP signaling pathway involved in ureter morphogenesis [BP],
ureter epithelial cell differentiation [BP],
positive regulation of cardiac muscle fiber development [BP]
synaptic vesicle endocytosis [BP]
GTP cyclohydrolase I activity [MF],
catecholamine metabolic process [BP],
VEGF-A-activated receptor activity [MF],
negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP],
placental growth factor-activated receptor activity [MF],
tetracycline transporter activity [MF],
cytotoxic T cell degranulation [BP],
integral to nuclear outer membrane [CC],
VEGF-B-activated receptor activity [MF],
tetracycline transport [BP],
7,8-dihydroneopterin 3'-triphosphate biosynthetic process [BP]
heme-transporting ATPase activity [MF],
inductive cell-cell signaling [BP]
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [BP],
histone H3-K4 acetylation [BP],
telomeric template RNA reverse transcriptase activity [MF]
positive regulation of Ras GTPase activity [BP]
T cell differentiation in thymus [BP]
extracellular-glutamate-gated ion channel activity [MF],
ionotropic glutamate receptor activity [MF]
synaptic vesicle to endosome fusion [BP],
serine-pyruvate aminotransferase complex [CC],
nucleoside phosphate kinase activity [MF],
nucleoside monophosphate phosphorylation [BP],
ornithine-oxo-acid transaminase activity [MF],
inductive cell-cell signaling [BP]
structural constituent of muscle [MF]
guanidinoacetate N-methyltransferase activity [MF],
regulation of interferon-gamma-mediated signaling pathway [BP],
kinase inhibitor activity [MF],
regulation of type I interferon-mediated signaling pathway [BP],
protein kinase inhibitor activity [MF],
regulation of growth [BP],
JAK-STAT cascade involved in growth hormone signaling pathway [BP],
ADP-specific glucokinase activity [MF]
3'-nucleotidase activity [MF]
anterior/posterior pattern specification [BP]
regulation of blood vessel size [BP],
cystathionine beta-synthase activity [MF],
cysteine biosynthetic process via cystathionine [BP],
cytoskeletal regulatory protein binding [MF],
homocysteine catabolic process [BP],
transsulfuration [BP],
cysteine biosynthetic process from serine [BP],
hydrogen sulfide biosynthetic process [BP],
sulfur amino acid metabolic process [BP],
glutamate-cysteine ligase complex [CC]
dendrite [CC],
protein localization to plasma membrane [BP]
protein kinase inhibitor activity [MF],
glutamate-tRNA ligase activity [MF]
DNA binding [MF]
lung epithelial cell differentiation [BP],
cardiac muscle cell proliferation [BP],
lung development [BP],
positive regulation of cell-cell adhesion mediated by integrin [BP],
branching morphogenesis of an epithelial tube [BP]
mitotic telophase [BP],
negative regulation of motor neuron apoptotic process [BP]
positive regulation of single-stranded telomeric DNA binding [BP]
nascent polypeptide-associated complex [CC]
group III metabotropic glutamate receptor activity [MF],
sphingomyelin synthase activity [MF],
ceramide cholinephosphotransferase activity [MF]
nucleosome [CC],
DNA binding [MF],
nucleus [CC]
positive regulation of cholesterol efflux [BP],
dehydroascorbic acid transport [BP],
MAPK export from nucleus [BP],
cellular hypotonic salinity response [BP],
hindlimb morphogenesis [BP]
DNA binding [MF],
regulation of transcription, DNA-dependent [BP],
zinc ion binding [MF]
positive regulation of hyaluronan biosynthetic process [BP],
paracrine signaling [BP],
metanephric glomerular endothelium development [BP],
metanephric glomerular mesangial cell development [BP],
positive regulation of glomerular filtration [BP],
cellular response to mycophenolic acid [BP],
positive regulation of metanephric mesenchymal cell migration [BP],
positive regulation of glomerular mesangial cell proliferation [BP],
positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [BP]
protein localization [BP]
ATP catabolic process [BP],
regulation of intracellular cholesterol transport [BP],
inhibition of mitotic anaphase-promoting complex activity [BP]
nucleus [CC]
myosin I complex [CC],
negative regulation of canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP],
positive regulation of glutamate-cysteine ligase activity [BP],
positive regulation of vascular endothelial growth factor signaling pathway [BP]
negative regulation of proteasomal ubiquitin-dependent protein catabolic process [BP],
sequence-specific DNA binding transcription factor activity [MF],
regulation of proteasomal ubiquitin-dependent protein catabolic process [BP],
sequence-specific DNA binding [MF],
embryo development [BP]
positive regulation of T cell mediated immune response to tumor cell [BP],
B cell cytokine production [BP],
positive regulation of skeletal muscle tissue growth [BP],
nascent polypeptide-associated complex [CC]
protein dephosphorylation [BP],
positive regulation of peptidyl-threonine phosphorylation [BP],
positive regulation of peptidyl-serine phosphorylation [BP],
lens fiber cell differentiation [BP]
nuclear condensin complex [CC]
cyclin-dependent protein kinase activity [MF],
peptidyl-serine phosphorylation [BP],
cyclin-dependent protein kinase holoenzyme complex [CC],
negative regulation of lipid storage [BP],
kinase activity [MF],
ATP binding [MF]
negative regulation of epithelial to mesenchymal transition [BP],
Wnt-protein binding [MF],
Wnt receptor signaling pathway involved in somitogenesis [BP],
negative regulation of cell growth [BP],
cellular response to X-ray [BP],
negative regulation of cytokine biosynthetic process [BP],
cellular protein metabolic process [BP],
regulation of transcription, DNA-dependent [BP],
transcription, DNA-dependent [BP],
negative regulation of peptidyl-tyrosine phosphorylation [BP],
convergent extension involved in axis elongation [BP],
positive regulation of fat cell differentiation [BP],
Wnt-activated receptor activity [MF],
transcription from RNA polymerase I promoter [BP],
negative regulation of Wnt receptor signaling pathway [BP],
negative regulation of planar cell polarity pathway involved in axis elongation [BP],
negative regulation of JUN kinase activity [BP],
planar cell polarity pathway involved in neural tube closure [BP]
Golgi apparatus [CC],
protein N-linked glycosylation via asparagine [BP]
cell proliferation [BP],
epidermal growth factor receptor signaling pathway [BP],
integral to lumenal side of endoplasmic reticulum membrane [CC],
cell surface receptor signaling pathway [BP],
glycogen cell differentiation involved in embryonic placenta development [BP],
MHC class I protein complex [CC],
T cell homeostasis [BP],
positive regulation of sequence-specific DNA binding transcription factor activity [BP],
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [BP],
cellular response to epidermal growth factor stimulus [BP],
ER to Golgi transport vesicle membrane [CC],
transmembrane receptor protein tyrosine kinase signaling pathway [BP],
translational attenuation [BP]
collagen type XVI [CC]
developmental growth [BP],
ureteric peristalsis [BP],
transcription, DNA-dependent [BP],
sequence-specific DNA binding [MF],
sequence-specific DNA binding transcription factor activity [MF],
negative regulation of Wnt receptor signaling pathway involved in digestive tract morphogenesis [BP],
cell migration involved in coronary vasculogenesis [BP],
DNA binding [MF],
negative regulation of motor neuron apoptotic process [BP]
positive regulation of JNK cascade [BP],
glucosidase II complex [CC],
cob(I)yrinic acid a,c-diamide adenosyltransferase activity [MF]
sulfate transport [BP],
secondary active sulfate transmembrane transporter activity [MF],
primitive hemopoiesis [BP],
integral to mitochondrial outer membrane [CC],
positive regulation of gene expression [BP],
regulation of ruffle assembly [BP]
alpha-1,6-mannosyltransferase activity [MF]
positive regulation of voltage-gated calcium channel activity [BP],
ventricular septum morphogenesis [BP],
fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [BP],
regulation of cardiac muscle cell proliferation [BP],
fibroblast growth factor receptor signaling pathway involved in hemopoiesis [BP],
cardiac muscle cell proliferation [BP],
ventricular cardiac muscle tissue morphogenesis [BP],
Purkinje myocyte differentiation [BP],
coronal suture morphogenesis [BP],
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow [BP],
atrioventricular node cell fate commitment [BP],
outflow tract septum morphogenesis [BP]
inositol-1,3,4-trisphosphate 6-kinase activity [MF],
secretin receptor activity [MF],
inositol-1,3,4-trisphosphate 5-kinase activity [MF]
positive regulation of Notch signaling pathway involved in heart induction [BP],
cardiac atrium formation [BP],
cardioblast migration to the midline involved in heart field formation [BP],
cardioblast anterior-lateral migration [BP],
sinus venosus morphogenesis [BP]
sequence-specific DNA binding transcription factor activity [MF],
hypothalamus development [BP]
cortical actin cytoskeleton [CC],
filamentous actin [CC]
spindle microtubule [CC],
regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter [BP],
spindle assembly [BP],
alpha-N-acetylgalactosaminidase activity [MF]
ATP citrate synthase activity [MF]
alpha-1,4-N-acetylgalactosaminyltransferase activity [MF],
regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter [BP]
positive regulation of epidermal growth factor receptor signaling pathway [BP]
abducens nerve formation [BP]
zymogen granule exocytosis [BP],
gastric emptying [BP],
cell cycle comprising mitosis without cytokinesis [BP]
cyclin-dependent protein kinase holoenzyme complex [CC],
neuron projection [CC]
dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [MF]
regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment [BP],
pancreatic A cell development [BP],
forebrain-midbrain boundary formation [BP],
termination of signal transduction [BP],
regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter [BP]
positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP],
positive regulation of protein catabolic process [BP]
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production [BP],
positive regulation of neutrophil extravasation [BP],
positive regulation of fibronectin-dependent thymocyte migration [BP],
activation of MAPK activity involved in innate immune response [BP],
dense core granule membrane [CC],
alpha9-beta1 integrin-ADAM8 complex [CC],
positive regulation of eosinophil migration [BP]
RNA polymerase II core promoter proximal region sequence-specific DNA binding [MF],
RNA polymerase II transcription coactivator activity [MF],
mannosyl-oligosaccharide glucosidase activity [MF],
superior vena cava morphogenesis [BP],
odontogenesis [BP],
ribonucleoprotein complex binding [MF],
prolactin secreting cell differentiation [BP],
optic cup structural organization [BP],
optic vesicle morphogenesis [BP],
embryonic camera-type eye development [BP],
subthalamic nucleus development [BP],
core promoter proximal region sequence-specific DNA binding [MF],
outflow tract morphogenesis [BP],
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription [MF],
RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription [MF],
methylenetetrahydrofolate reductase (NADPH) activity [MF],
neural crest cell development [BP]
protein glycosylation in Golgi [BP],
regulation of establishment of cell polarity [BP],
activation of cysteine-type endopeptidase activity involved in apoptotic process [BP],
mesoderm morphogenesis [BP],
embryonic skeletal joint development [BP]
histone deacetylase complex [CC],
inductive cell-cell signaling [BP],
regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP],
ethanolamine-phosphate cytidylyltransferase activity [MF]
regulation of grooming behavior [BP],
alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor clustering [BP],
P2Y1 nucleotide receptor binding [MF],
ADP-activated nucleotide receptor activity [MF],
serine-type endopeptidase activity [MF]
olfactory bulb development [BP],
nucleus [CC]
MAP kinase kinase kinase activity [MF],
transcription factor TFIIE complex [CC]
metanephric connecting tubule development [BP],
methionine-R-sulfoxide reductase activity [MF]
UBC13-UEV1A complex [CC],
nucleus [CC]
RNA processing [BP],
snRNA import into nucleus [BP]
abducens nerve formation [BP],
porphobilinogen synthase activity [MF],
lead ion binding [MF]
3'(2'),5'-bisphosphate nucleotidase activity [MF],
sphingolipid metabolic process [BP],
alpha-galactosidase activity [MF],
3'-nucleotidase activity [MF]
myosin I complex [CC],
lipid particle [CC],
positive regulation of vascular endothelial growth factor signaling pathway [BP]
regulation of blood pressure [BP]
3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [MF],
negative regulation of metanephric glomerular mesangial cell proliferation [BP]
extrinsic to Golgi membrane [CC],
histone H3-K4 demethylation, trimethyl-H3-K4-specific [BP],
histone demethylase activity (H3-trimethyl-K4 specific) [MF],
ribonuclease T2 activity [MF],
response to brefeldin A [BP]
glycerol ether metabolic process [BP],
regulation of microvillus assembly [BP],
protein disulfide oxidoreductase activity [MF]
acetylcholine receptor activator activity [MF]
heme-transporting ATPase activity [MF],
2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [MF],
cadmium ion transmembrane transport [BP],
histone deacetylase binding [MF],
3-demethylubiquinone-9 3-O-methyltransferase activity [MF],
detoxification of cadmium ion [BP],
hexaprenyldihydroxybenzoate methyltransferase activity [MF]
sequence-specific DNA binding transcription factor activity [MF]
dehydroascorbic acid transport [BP],
acetyl-CoA transport [BP]
positive regulation of voltage-gated calcium channel activity [BP],
ventricular septum morphogenesis [BP],
glucuronosyltransferase activity [MF],
cardiac muscle contraction [BP],
regulation of cardiac muscle contraction [BP],
ventricular cardiac muscle tissue morphogenesis [BP],
heme-transporting ATPase activity [MF],
Purkinje myocyte differentiation [BP],
cardiac muscle tissue morphogenesis [BP],
atrioventricular node cell fate commitment [BP]
presynaptic active zone membrane [CC]
membrane hyperpolarization [BP],
GTP catabolic process [BP],
integral to mitochondrial outer membrane [CC],
regulation of Rho GTPase activity [BP]
negative regulation of tooth mineralization [BP],
negative regulation of histone H3-K36 methylation [BP],
negative regulation of histone H3-K4 methylation [BP]
compact myelin [CC],
myelin sheath [CC],
dolichol kinase activity [MF]
ethanolamine-phosphate cytidylyltransferase activity [MF]
glutamate receptor signaling pathway [BP]
18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [MF],
positive regulation of cytoplasmic translation [BP]
thiopurine S-methyltransferase activity [MF],
menstruation [BP],
brain development [BP],
regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter [BP]
negative regulation of collateral sprouting [BP],
clathrin-sculpted monoamine transport vesicle membrane [CC]
DNA rewinding [BP],
urocanate hydratase activity [MF],
cerebellar mossy fiber [CC],
Type I pneumocyte differentiation [BP],
negative regulation of epithelial cell proliferation involved in lung morphogenesis [BP],
principal sensory nucleus of trigeminal nerve development [BP]
nucleus [CC]
vascular endothelial growth factor receptor-1 signaling pathway [BP],
positive regulation of vascular endothelial growth factor signaling pathway [BP],
placental growth factor-activated receptor activity [MF],
VEGF-B-activated receptor activity [MF],
cellular response to vascular endothelial growth factor stimulus [BP],
3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [MF],
myosin I complex [CC],
VEGF-A-activated receptor activity [MF]
poly-glutamine tract binding [MF]
sphingosine N-acyltransferase activity [MF]
nucleosome [CC]
protein kinase C binding [MF],
positive regulation of glutamate-cysteine ligase activity [BP]
histone H2A-S1 phosphorylation [BP],
collagen type XVI [CC],
mitochondrial chromosome [CC],
optic cup structural organization [BP]
inositol-1,3,4-trisphosphate 6-kinase activity [MF],
lanosterol synthase activity [MF],
inositol-1,3,4-trisphosphate 5-kinase activity [MF]
ATPase binding [MF]
salivary gland morphogenesis [BP],
positive regulation of MAP kinase activity [BP],
commitment of neuronal cell to specific neuron type in forebrain [BP],
regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment [BP],
pancreatic A cell development [BP],
forebrain-midbrain boundary formation [BP],
transforming growth factor beta receptor signaling pathway [BP]
borate transport [BP],
phosphoenolpyruvate-dependent sugar phosphotransferase system [BP],
ethanolamine-phosphate phospho-lyase activity [MF],
borate transmembrane transport [BP]
negative regulation of protein kinase B signaling cascade [BP],
response to antibiotic [BP]
mammary gland bud elongation [BP],
E-box binding [MF],
nipple sheath formation [BP],
negative regulation of macrophage inflammatory protein 1 alpha production [BP]
N-acetylglucosamine metabolic process [BP]
galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity [MF],
sequence-specific DNA binding [MF]
inositol-1,3,4-trisphosphate 6-kinase activity [MF],
inositol-1,3,4-trisphosphate 5-kinase activity [MF],
ADP-specific glucokinase activity [MF],
3-hydroxyisobutyryl-CoA hydrolase activity [MF]
sulfur compound metabolic process [BP],
chondroitin sulfate proteoglycan biosynthetic process [BP],
sulfur amino acid catabolic process [BP],
endochondral ossification [BP]
bud dilation involved in lung branching [BP],
ureter epithelial cell differentiation [BP],
specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway [BP],
negative regulation of glomerulus development [BP],
negative regulation of mesenchymal cell proliferation involved in ureter development [BP],
negative regulation of metanephric comma-shaped body morphogenesis [BP],
liver development [BP],
negative regulation of cell proliferation involved in heart morphogenesis [BP],
negative regulation of metanephric S-shaped body morphogenesis [BP],
epithelial cell development [BP],
BMP signaling pathway involved in nephric duct formation [BP],
negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway [BP],
endocrine pancreas development [BP],
pulmonary artery endothelial tube morphogenesis [BP],
intermediate mesodermal cell differentiation [BP],
BMP signaling pathway involved in ureter morphogenesis [BP],
translational attenuation [BP],
positive regulation of cardiac muscle fiber development [BP]
core promoter proximal region DNA binding [MF],
type B pancreatic cell fate commitment [BP]
activation of protein kinase A activity [BP],
water transport [BP],
cAMP-dependent protein kinase complex [CC]
skin development [BP],
positive regulation of cytoplasmic translation [BP],
metanephric nephron development [BP],
metanephric distal tubule morphogenesis [BP],
optic cup structural organization [BP],
optic vesicle morphogenesis [BP],
cochlea development [BP],
abducens nerve formation [BP],
inner ear development [BP],
embryonic cranial skeleton morphogenesis [BP]
optokinetic behavior [BP],
abducens nerve formation [BP],
glutathione synthase activity [MF],
citrate (Si)-synthase activity [MF]
embryonic digit morphogenesis [BP],
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [BP]
rhombomere 5 formation [BP]
positive regulation of antigen processing and presentation of peptide antigen via MHC class I [BP],
transcription factor TFIIIB complex [CC],
cellular response to amino acid starvation [BP],
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent [BP],
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent [BP]
ion channel inhibitor activity [MF],
Notch receptor processing [BP]
structural constituent of cell wall [MF],
calcium ion-dependent exocytosis of neurotransmitter [BP],
cell dedifferentiation [BP]
regulation of cell adhesion [BP],
negative regulation of osteoblast differentiation [BP],
regulation of osteoblast differentiation [BP],
osteoblast differentiation [BP],
negative regulation of myeloid cell differentiation [BP],
growth hormone receptor signaling pathway [BP],
non-membrane spanning protein tyrosine kinase activity [MF],
negative regulation of cell differentiation [BP],
regulation of focal adhesion assembly [BP],
positive regulation of cell-matrix adhesion [BP],
positive regulation of cell adhesion [BP],
hematopoietic stem cell differentiation [BP]
ephrin receptor signaling pathway [BP]
sequence-specific DNA binding RNA polymerase II transcription factor activity [MF],
RNA polymerase II transcription corepressor activity [MF]
negative regulation of SNARE complex assembly [BP],
synaptic vesicle exocytosis [BP]
cortical microtubule cytoskeleton [CC]
negative regulation of norepinephrine secretion [BP]
response to cycloheximide [BP],
cytosolic proteasome complex [CC]
cell-cell signaling involved in mammary gland development [BP],
GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [MF]
metanephric mesenchyme development [BP],
thyroid gland development [BP],
thymus development [BP],
positive regulation of mesenchymal cell proliferation involved in ureter development [BP]
positive regulation of cell-cell adhesion [BP]
positive regulation of Notch signaling pathway involved in heart induction [BP],
cardiac atrium formation [BP],
cardioblast migration to the midline involved in heart field formation [BP],
cardioblast anterior-lateral migration [BP],
sinus venosus morphogenesis [BP]
gene expression [BP],
Rac GTPase binding [MF]
spindle midzone assembly involved in mitosis [BP],
chromosome passenger complex [CC]
anatomical structure morphogenesis [BP],
epithelial cell morphogenesis [BP],
maintenance of presynaptic active zone structure [BP],
striatal medium spiny neuron differentiation [BP],
regulation of cell differentiation [BP],
leading edge cell differentiation [BP],
axon guidance [BP],
cellular response to potassium ion starvation [BP],
olfactory bulb axon guidance [BP],
collagen type II [CC],
multicellular organismal development [BP],
RNA polymerase II core promoter proximal region sequence-specific DNA binding [MF],
cell differentiation [BP]
response to testosterone stimulus [BP],
aminopeptidase activity [MF]
neural fold bending [BP]
negative regulation of interleukin-13 secretion [BP]
transcription elongation factor complex [CC],
VEGF-B-activated receptor activity [MF],
VEGF-A-activated receptor activity [MF],
placental growth factor-activated receptor activity [MF]
nuclear membrane [CC],
L-phenylalanine:pyruvate aminotransferase activity [MF],
L-phenylalanine-oxaloacetate transaminase activity [MF],
L-glutamine:pyruvate aminotransferase activity [MF],
nuclear envelope [CC],
GTP cyclohydrolase I activity [MF],
7,8-dihydroneopterin 3'-triphosphate biosynthetic process [BP],
nucleus [CC]
Rab guanyl-nucleotide exchange factor activity [MF],
social behavior [BP],
axon guidance [BP],
regulation of long-term neuronal synaptic plasticity [BP],
P2Y1 nucleotide receptor binding [MF]
commitment of neuronal cell to specific neuron type in forebrain [BP],
pancreatic A cell development [BP],
regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment [BP],
tRNA 2'-phosphotransferase activity [MF]
embryonic skeletal system development [BP],
glial cell differentiation [BP],
brain development [BP],
central nervous system development [BP],
sequence-specific DNA binding [MF],
sequence-specific DNA binding transcription factor activity [MF],
nucleic acid binding [MF],
negative regulation of gene expression [BP],
forebrain development [BP],
transcription from RNA polymerase II promoter [BP],
rhombomere development [BP],
skeletal system development [BP]
regulation of mesenchymal cell proliferation involved in prostate gland development [BP],
dynein light chain binding [MF],
positive regulation of skeletal muscle cell proliferation [BP],
negative regulation of kidney smooth muscle cell differentiation [BP],
multicellular structure septum development [BP],
negative regulation of ureter smooth muscle cell differentiation [BP],
positive regulation of ureter smooth muscle cell differentiation [BP],
positive regulation of sclerotome development [BP],
positive regulation of kidney smooth muscle cell differentiation [BP]
serotonin:sodium symporter activity [MF],
cocaine binding [MF]
seminal clot liquefaction [BP],
histone demethylase activity (H3-K27 specific) [MF]
histone H3-K4 acetylation [BP],
positive regulation of single-stranded telomeric DNA binding [BP]
glial cell differentiation [BP],
regulation of transcription, DNA-dependent [BP],
negative regulation of transcription, DNA-dependent [BP],
chromatin binding [MF],
negative regulation of gene expression [BP],
regulation of transcription from RNA polymerase II promoter [BP]
rhombomere 5 development [BP],
facial nerve structural organization [BP],
sequence-specific DNA binding transcription factor activity [MF],
glossopharyngeal nerve morphogenesis [BP],
sequence-specific DNA binding [MF],
anterior/posterior pattern specification [BP],
facial nucleus development [BP],
pattern specification process [BP],
rhombomere 4 development [BP],
rhombomere development [BP]
hexose transmembrane transport [BP],
nascent polypeptide-associated complex [CC]
MLL1 complex [CC],
histone H4-K16 acetylation [BP]
proepicardium development [BP],
positive regulation of voltage-gated calcium channel activity [BP],
Purkinje myocyte differentiation [BP],
collagen type XII [CC]
mitochondrial proton-transporting ATP synthase complex [CC]
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway [BP],
myosin complex [CC]
establishment of apical/basal cell polarity [BP],
negative regulation of mitotic cell cycle [BP],
protein kinase activator activity [MF],
salivary gland development [BP]
protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF],
cAMP response element binding protein binding [MF],
positive regulation of axonogenesis [BP]
myosin II heavy chain binding [MF],
skeletal muscle tissue development [BP],
mammary placode formation [BP],
atrioventricular bundle cell differentiation [BP],
sinoatrial node cell development [BP]
DNA topological change [BP]
mitotic nuclear envelope reassembly [BP]
transcription coactivator activity [MF],
histone H3 acetylation [BP],
transcription factor TFTC complex [CC],
histone acetyltransferase activity [MF]
